Viewing Study NCT01715168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-07 @ 11:23 AM
Study NCT ID: NCT01715168
Status: UNKNOWN
Last Update Posted: 2015-01-15
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Sponsor: Azaya Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Malignant Female Reproductive System Neoplasm View
None Cancer View
None Ovarian Tumor View
None Ovarian Epithelial Cancer Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Doxil generic View
None Caelyx generic View
None generic treatment View
None ovarian cancer View
None ovary View
None progressed View
None recurred cancer View
None platinum based therapy View